HOOKIPA Pharma Inc.
DelistedCIK 1760542fmd_1ATS6A216P4FSQF7CMJ5WCBA55Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2017 to Mar 31, 2025, 30 periods
| Line item | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|---|---|---|
| Total revenues | – | 8 | 12 | 20 | 18 | 14 | 20 | 44 |
| Research and development | 10 | 22 | 46 | 55 | 83 | 69 | 86 | 69 |
| Operating income | (14) | (21) | (51) | (53) | (82) | (73) | (98) | (51) |
| Interest expense | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 |
| Interest and investment income | – | 0 | 2 | 0 | 0 | 2 | 5 | 4 |
| Other non-operating income (expense) | 1 | 5 | 8 | 9 | 6 | 8 | 16 | 8 |
| Income before taxes | (13) | (16) | (43) | (44) | (76) | (65) | (81) | (44) |
| Income tax expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (0) |
| Net income from continuing operations | (13) | (16) | (43) | (44) | (76) | (65) | (82) | (44) |
| Net income | (13) | (16) | (43) | (44) | (76) | (65) | (82) | (44) |